Pharma

Muscle-building supplements are hugely popular with Canadian boys and young men: That’s a problem

The portrayal of muscular male bodies is a new but increasingly common phenomenon driving demand for potentially harmful muscle-building supplements. Young people in particular are at risk.

From diabetes medication to weight-loss wonder drug: Ozempic’s popularity raises big questions

Ozempic has raised a lot of questions. We asked a panel of experts what are the most important factors to consider when prescribing Ozempic for weight loss.

Postpartum depression isn’t the biggest issue for mothers. Postpartum anxiety is

Postpartum anxiety is more than three times more prevalent than postpartum depression yet we hear about it far less often.

Sometimes the truth is unbearable

The health-care system is failing Canadians with lethal consequences. Policymakers need to make urgent changes now to address delays in access to care.

The case for a pan-Canadian licensure model

Canada’s workforce remains in crisis. With hospital overcrowding and staff shortages putting EDs at risk, pan-Canadian licensure is a crucial part of any plan to help ease the pressure.

The real cost of not adopting universal pharmacare is Canadian lives

Pharmacare has not yet been implemented and the pandemic – and the supply and confidence agreement – only further entrenched Big Pharma’s power in Ottawa. But patients need access to life-saving medications.

The placebo effect: Rarely dramatic, but surprisingly consistent and adjustable

‘Bogus contract’ creating gulf between doctors, patients

There are unhealthy expectations built into the "bogus contract" between doctors and patients that overemphasize the power of medicine. At the same time, we are ignoring the relative importance of the precursors to good health.

Diet vs. drugs – Comparing the effects of diet with leading pharmaceuticals

In 440 B.C., Hippocrates famously said “Let food be thy medicine.” More than 2,000 years later, the evidence to substantiate this statement has never been more robust.

Dear family doc: We’re all in this together

During these challenging times – just like during the height of the pandemic – we need every health-care provider doing his or her part. Ontario pharmacists are here to help.

B.C.’s ‘necessary step forward’ in drug decriminalization

B.C. is Canada’s first jurisdiction to be granted a federal exemption to decriminalize personal drug possession up to 2.5 grams. Other provinces may soon follow suit.

Dr. Pharmacist?

Pharmacists can prescribe medications for certain ailments in eight provinces with Ontario about to follow suit. But while pharmacists knowledge of medications is invaluable, are they diagnosticians?

Over-the-counter ointments are ‘poison ivy in a tube’ for some, dermatologists warn

Canada’s most popular over-the-counter ointments for wound treatment are the most common medical substances causing allergic contact dermatitis, or ACD.

What’s on a label? This simple intervention could improve patient safety and save money

Adding reason for use to the labels of prescriptions could be an opportunity to support patient health literacy and to improve communication within the health-care team.

New drug to treat prostate cancer may be out of reach for most Canadians

A new, last-hope prostate cancer treatment has been approved by Health Canada but may be out of reach for most of the more than 4,500 men who die of the disease each year.

What to know about bivalent vaccines

Health Canada authorized the most recent bivalent vaccine to date, a Moderna booster, to target multiple strains of the COVID-19 virus. But what exactly is a bivalent vaccine? And is it safe? Here's all you need to know.

Antimicrobial resistance: ‘Slow-moving tsunami’ now coming fast and furious

Antimicrobial resistance long has been described as a “slow-moving tsunami,” suggesting its only likely to occur in some far-distant future. It may seem that we do not need to take immediate action because there is still time … but is there?

Move to generic methadone raises concerns

Ontario’s move away from brand name Methadose has sparked concerns the switch could negatively impact those who rely on the drug, prompting calls for more buy-in from methadone users ahead of these changes.

In ‘Heroin,’ author lays bare the injustice and systemic racism behind Canada’s drug laws

For International Overdose Awareness Day (Aug. 31), Healthy Debate sat down with Dr. Susan Boyd to discuss her latest book, Heroin: An Illustrated History.

An update on national pharmacare, and five steps to get us there faster

The current state of our health system means viable alternative approaches are needed. Private plans are not perfect, and neither are provincial plans. But both payer groups need to better protect Canadians from ruinous drug costs.